TECH BUYER Jul 2021 - IDC Perspective - Doc # US48024721
Leveraging Telehealth to Accelerate Clinical Trials
Abstract
This IDC Perspective provides deep insight into the key drivers fueling the increasing importance of telehealth solutions in clinical trials. It also analyzes the existing challenges and complexities and provides an insight into the market landscape, outlining different technology solutions.
"With the heightened need to ensure patient safety, an increased focus on 'patient centricity,' the rapid acceleration in the growth of decentralized trials, and favorable updates to regulations, telehealth has taken center stage, with multiple providers vying to develop single sign-on, user-friendly, and secure solutions that can integrate with EDC solutions and embed eCOA and econsent capabilities as well. While telehealth can certainly increase access to patients, care should be taken to ensure suitability of this solution based on the types of visits and procedures and patient optionality should come first," says Dr. Nimita Limaye, research VP, Life Sciences R&D at IDC.
Coverage
Subscriptions Covered
IDC Health Insights: Worldwide Life Science R&D Strategy and Technology
Companies Covered
Verizon Communications, Inc., Definitive Media Corp, Tata Consultancy Services Limited, Atos SE, ERT, ELLIGO HEALTH RESEARCH, INC., IQVIA Inc., Veeva Systems Inc., MEDABLE INC.., LifeLink.com, Inc., Medidata Solutions, Inc., NTT DATA Corporation, SCIENCE 37, INC., Infosys Limited
Regions Covered
Topics Covered
Content management, Customer relationship management applications, Technology buyer, VoIP, Wearables, eLearning
Vertical Markets
Health delivery strategies, Health treatment strategies, Knowledge-based medicine
Content
List of Figures
Get More
When you purchase this document, the purchase price can be applied to the cost of an annual subscription, giving you access to more research for your investment.